Lisa Rapaport

Lisa Rapaport is a health journalist who covers topics related to medicine, science, and health policy. She has written extensively about the impact of diet and lifestyle on chronic conditions such as diabetes, heart disease, and Alzheimer's. Her work often highlights the latest research findings and medical advancements in these areas. In addition to her reporting on specific health topics, Rapaport also provides context on broader healthcare issues such as drug pricing, access to care, and public health policy.

10%

The Daily's Verdict

This author has a poor reputation for journalistic standards and is not considered a reliable news source.

Bias

10%

Examples:

  • Lisa Rapaport appears to have a neutral reporting style with no clear signs of editorial or personal bias in her articles.

Conflicts of Interest

10%

Examples:

  • There are no conflicts of interest identified in Lisa Rapaport's articles.

Contradictions

10%

Examples:

  • There are no contradictions found in Lisa Rapaport's articles.

Deceptions

10%

Examples:

  • There are no deceptive practices found in Lisa Rapaport's articles.

Recent Articles

Preserving Leg Strength in Retirement: The Long-Term Benefits of Heavy Resistance Training

Preserving Leg Strength in Retirement: The Long-Term Benefits of Heavy Resistance Training

Broke On: Wednesday, 19 June 2024 Recent studies led by Carl-Johan Boraxbekk and Mads Bloch-Ibenfeldt reveal that heavy resistance training preserves leg strength in older adults for several years, improving everyday functional movements and predicting physical functionality later in life.
Ultra-Processed Foods: The Silent Culprit of Memory Problems, Stroke Risk, and Addiction

Ultra-Processed Foods: The Silent Culprit of Memory Problems, Stroke Risk, and Addiction

Broke On: Wednesday, 29 May 2024 New research reveals that ultra-processed foods, high in added sugars, sodium, and unhealthy fats, can negatively impact cognitive function and overall health. Consuming these foods is linked to memory problems, thinking abilities impairment, increased stroke risk, and addiction potential (Sources A-D). To maintain optimal brain health and reduce the risk of cognitive decline and stroke, focus on consuming whole or minimally processed foods as part of a balanced diet (Source E).
One in Eight Americans Use GLP-1 Drugs for Chronic Conditions or Weight Loss: Affordability and Access Remain Challenges

One in Eight Americans Use GLP-1 Drugs for Chronic Conditions or Weight Loss: Affordability and Access Remain Challenges

Broke On: Wednesday, 15 May 2024 One in eight adults in the US have used GLP-1 drugs like Ozempic or Mounjaro, primarily for managing chronic conditions or weight loss. Despite their popularity, affordability is a major concern, with half of users finding it difficult to pay. Older adults and those without Medicare coverage are particularly affected by shortages and high costs. Six in ten adults advocate for Medicare coverage for weight loss medications, but current policy prohibits it.